SG Americas Securities, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 38 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,702,000
-10.6%
13,0000.0%0.01%
+20.0%
Q4 2021$1,903,000
-1.2%
13,0000.0%0.01%
+11.1%
Q3 2021$1,926,000
+16.7%
13,000
+4.0%
0.01%
+12.5%
Q2 2021$1,651,000
-49.5%
12,500
-50.0%
0.01%
-52.9%
Q1 2021$3,272,000
-29.8%
25,000
+31.6%
0.02%
-32.0%
Q4 2020$4,663,000
+1023.6%
19,000
+850.0%
0.02%
+733.3%
Q3 2020$415,000
-63.9%
2,000
-60.0%
0.00%
-70.0%
Q2 2020$1,149,000
-76.4%
5,000
-84.4%
0.01%
-78.3%
Q1 2020$4,865,000
-63.3%
32,000
-52.9%
0.05%
-62.0%
Q4 2019$13,243,00068,0000.12%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
DLD Asset Management, LP 10,370,000$18,432,6751.98%
Worth Venture Partners, LLC 1,431,000$2,536,6771.50%
CSS LLC/IL 8,197,000$14,535,1420.95%
TENOR CAPITAL MANAGEMENT Co., L.P. 5,198,000$9,252,6470.20%
Warberg Asset Management LLC 517,000$911,5800.18%
BOOTHBAY FUND MANAGEMENT, LLC 3,889,000$6,893,8770.16%
PALISADE CAPITAL MANAGEMENT, LP 1,000,000$1,765,6250.05%
Point72 Asset Management, L.P. 9,007,000$15,925,0090.05%
CAPSTONE INVESTMENT ADVISORS, LLC 5,082,000$8,984,9760.04%
D. E. Shaw & Co., Inc. 11,089,000$19,645,1130.02%
View complete list of SAREPTA THERAPEUTICS INC shareholders